PFE > interesting factoid... Despite having spent some $240bn on three big acquisitions since 2000, its market capitalisation is just $185bn today. Meanwhile the Dow Jones index is more than 40 per cent higher. The real choice that AstraZeneca faces http://www.ft.com/intl/cms/s/2/207666be-d78c-11e3-b381-00144feabdc0.html#axzz31YDe6Yxc
Market Data 
Markets 
AI
